Previous reports indicated that the upregulation of ZEB1 by TGF-β or other cytokines/growth factors is accompanied by ZEB2 upregulation [40], and that both ZEB1 and ZEB2 are highly expressed in breast cancer cells with aggressive phenotypes [9]. Here, ZEB2 is linked to breast carcinoma.